3036-A PREVENTION OF MORTALITY WITH LONG-TERM HUMAN ALBUMIN ADMINISTRATION IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND ASCITES: DESIGN AND STATUS OF THE PRECIOSA STUDY Tarek Hassanein 1 , Paolo Angeli 2 , Wim Laleman 3 , Tamara Milanovic 4 , Gergana Taneva 5 , Mireia Torres 6 , Peter Nelson 6 , Javier Fernandez 7,8 and On behalf of the PRECIOSA Study Investigators, (1)Southern California Research Center, (2)Padua Hospital University, (3)University Hospital Gasthuisberg, KU Leuven, (4)University Clinical Center of Serbia, (5)Saint Sophia Medical College, (6)Grifols, (7)Hospital Clnic, Idibaps and Ciberehd, (8)EF Clif, Easl-Clif Consortium and Grifols Chair Background: Patients with decompensated cirrhosis develop ascites, variceal bleeding, hepatic encephalopathy, and bacterial infections, complications associated with worse survival compared to compensated cirrhosis
References & Links Di Lullo G, Sweeney S, Korkko J, Ala-Kokko L, San Antonio J
Additionally, 59% have vomiting
How Long Should Semaglutide Be Used For Weight Loss
Wegovy dosing schedule and what to expect Managing side effects and tips that work Pricing, delivery, and how to get started Why Might Leg Cramps Occur During GLP-1 Treatment